Medicare Enrolled

Dr. Stefan Lowenstein, MD

Student in an Organized Health Care Education/Training Program · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2425 GEARY BLVD, San Francisco, CA 94115
4158332000
In practice since 2018 (7 years)
NPI: 1245728807 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lowenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lowenstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lowenstein

Dr. Stefan Lowenstein is a student in an organized health care education/training program specialist in San Francisco, CA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Lowenstein performed 3,268 Medicare services across 1,670 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lowenstein received a total of $4,186 from 22 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lowenstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice ▲ Top 5% volume in CA $4,186 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,268
Medicare services
Top 5% in CA for student in an organized health care education/training program
1,670
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~467 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,197 $7 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
598 $73 $165
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
403 $48 $130
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
295 $92 $210
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
138 $1 $3
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
109 $102 $235
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
78 $103 $225
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
77 $51 $105
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
73 $84 $205
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
54 $44 $110
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $48 $105
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
39 $382 $840
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
33 $543 $1,310
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 27 $395 $805
Complicated wound repair, 2.6-7.5 cm
A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet.
23 $273 $925
Surgical removal of skin cancer, 2.1-3.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters.
22 $133 $540
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
20 $157 $345
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
19 $121 $480
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
14 $171 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,186
Total received (2022-2024)
Avg $1,395/year across 3 years
Top 8% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,186 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,027
2023
$1,733
2022
$426

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$672
LEO Pharma Inc.
$580
PFIZER INC.
$305
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
SUN PHARMACEUTICAL INDUSTRIES INC.
$70
Regeneron Healthcare Solutions, Inc.
$60
E.R. Squibb & Sons, L.L.C.
$44
Organogenesis Inc.
$44
Janssen Biotech, Inc.
$37
Biofrontera Inc.
$28
GENZYME CORPORATION
$26
MERZ NORTH AMERICA, INC.
$24
UCB, Inc.
$23
Arcutis Biotherapeutics, Inc.
$17
Amgen Inc.
$17
Top 3 companies account for 76.9% of 2024 payments
All-time payments by company (2022-2024) ›
LEO Pharma Inc.
$1,387
ABBVIE INC.
$1,149
PFIZER INC.
$555
Amgen Inc.
$169
Janssen Biotech, Inc.
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
Regeneron Healthcare Solutions, Inc.
$112
Lilly USA, LLC
$86
GENZYME CORPORATION
$74
SUN PHARMACEUTICAL INDUSTRIES INC.
$70
Novartis Pharmaceuticals Corporation
$57
E.R. Squibb & Sons, L.L.C.
$44
Organogenesis Inc.
$44
Janssen Scientific Affairs, LLC
$34
Galderma Laboratories, L.P.
$31
Biofrontera Inc.
$28
Incyte Corporation
$27
MERZ NORTH AMERICA, INC.
$24
UCB, Inc.
$23
Arcutis Biotherapeutics, Inc.
$17
Merz North America, Inc.
$14
Sun Pharmaceutical Industries Inc.
$14
Top 3 companies account for 73.9% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · BOTOX · Bimzelx · CIBINQO · CYLTEZO · DUPIXENT · DYSPORT · EUCRISA · HUMIRA · ILUMYA · OPZELURA · Otezla · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · Winlevi · XOLAIR · Xeomin · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for student in an organized health care education/training program in CA.

Looking for a student in an organized health care education/training program specialist in San Francisco?
Compare student in an organized health care education/training programs in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
5,486
Per 100K population
656.0
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lowenstein is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 8% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lowenstein experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lowenstein performed 1,197 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lowenstein receive payments from pharmaceutical companies?
Yes. Dr. Lowenstein received a total of $4,186 from 22 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lowenstein's costs compare to other student in an organized health care education/training programs in San Francisco?
Dr. Lowenstein's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lowenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →